Bristol Myers Squibb shares rise 3.7% as the company negotiates a potential merger with AstraZeneca.
Jin1008/03, 08:32 PM
Related assets
Coming up for BMY
Explore next
Latest BMY news
Jin1008/05, 07:04 PM
Astrazeneca and Bristol Myers Squibb have no ongoing discussions regarding a potential transaction.
Finnhub08/04, 12:17 AM
Finnhub08/03, 10:50 PM